Tandem Diabetes Care (TNDM) Stock: Buy, Sell, or Hold?
TNDM - Tandem Diabetes Care, Inc.
$16.50
0.19 (1.16%)
▲
5d:
+8.41%
30d:
-22.46%
90d:
+7.7%
HOLD
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When TNDM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TNDM shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: TNDM shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: TNDM is currently trading at $16.50, which is considered slightly low relative to its 30-day fair value range of $16.34 to $20.77. From a valuation perspective, the stock is trading at a discount (Forward PE: 98.4) compared to its historical average (190.5). Remarkably, the market is currently pricing in an annual earnings decline of 19.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TNDM is in a strong downtrend. Immediate support is located at $14.83, while resistance sits at $18.03.
Market Sentiment: TNDM scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $28.35 (+71.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TNDM is in a strong downtrend. Immediate support is located at $14.83, while resistance sits at $18.03.
Market Sentiment: TNDM scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $28.35 (+71.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$16.34 -
$20.77
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
90.5%
Protect Your Profits
Holding TNDM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 71.8% below Wall St target ($28.35)
- CAUTION: Bottoming setup, but lagging the sector by 32% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$16.34 -
$20.77
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$14.83
Resistance Level
$18.03
Current Trend
Strong Downtrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
98.39
Wall Street Target
$28.35
(+71.8%)
Revenue Growth (YoY)
5.8%
Earnings Growth (YoY)
-37.0%
Profit Margin
-6.1%
Valuation Discount vs History
-19.8% cheaper
PE vs Historical
98.4 vs 190.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-19.8%
(market-implied from PE analysis)
1-Year Target
$14.85
(-10%)
2-Year Target
$13.37
(-19%)
3-Year Target
$12.03
(-27%)
3-Yr Target (if PE normalizes)
(PE: 98→191)
$23.29
(+41%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 98.4 to 190.5
Stabilization Target:
$31.95
(+93.6%)
PE Expansion Potential:
+93.6%
Share & Embed Analysis
Last updated: October 02, 2026 2:21 AM ET
Data refreshes hourly during market hours. Next update: 3:21 AM
Data refreshes hourly during market hours. Next update: 3:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNDM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 62 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 64 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 49 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 44 HOLD |
Advanced TNDM Option Strategies
Professional options setups generated by AI based on today's TNDM price and gamma walls.
